were obtained when comparing the most frequent DRD4 exon III genotypes (24 vs 44 vs 47 genotype: F 2,220 = 2.35, P = 0.10) With regard to a potential association between the DRD4 −521C/T polymorphism and Novelty Seeking, analyses of variance showed that individuals with distinct −521C/T genotypes (CC vs CT vs TT) did not differ in their Novelty Seeking scores (F 2,273 = 0.31, P = 0.74). Furthermore, no significant differences emerged when comparing CC vs CT & TT genotypes (F 1,275 = 0.02, P = 0.89). This grouping was based on the functional role of the T allele and on the findings of Ronai et al. 6 Finally, no gender-specific associations between −521C/T and Novelty Seeking emerged as might be expected from previous results 6 (data not shown).
In subsequent analyses based on DRD4 exon III × −521C/T haplotypes, there were no significant differences in Novelty Seeking between groups based on haplotypes, neither when constructing (exon III 7 repeat absent/present) × (−521 CC/CT/TT) haplotypes nor when constructing (exon III 24/44/47 genotypes) × (−521 CC/CT/TT) haplotypes (one-way analyses of variance, all P Ͼ 0.05).
In conclusion, our data do not provide evidence for associations between the two DRD4 polymorphisms and Novelty Seeking. Several reasons may account for our failure to replicate the reported associations. First, our sample may not have provided sufficient power to detect an association between the DRD4 polymorphisms and Novelty Seeking. However, several previous studies reporting associations between Novelty Seeking and DRD4 exon III, 1, 3 or −521C/T 5, 6 have been based on samples of much smaller size. Therefore, we should have been able to detect associations between the two DRD4 polymorphisms and Novelty Seeking. Second, the possibility of false negative results due to stratification effects cannot be completely ruled out as a source of error in our sample of unrelated individuals, even though all participants were of German ethnicity and there were no influences of age and gender (data not shown). Finally, developmental factors and compensatory interactions with other biological mechanisms may account for the presence or absence of a phenotypic effect of a given functional polymorphism. Although functional differences have been reported between DRD4 exon III variants, 8 and between DRD4 −521C/T variants, 5 respectively, the pathways in which these functional differences affect behavioral variation remain to be fully understood. 3, 4 makes the association controversial. In 5-HTTLPR polymorphism, a 44-bp insertion or deletion, the transcriptional activity of the short (S) variant is half that of the long (L) variant, leading to a 50% decrease in 5-HTT expression and 5-HT uptake. 5 If an association between abnormal eating behaviors and 5-HTTLPR really exists, it should be observable even in non-clinical subjects, and there should be dif- ferences between the distribution of 5-HTTLPR genotypes and alleles in subjects with abnormal eating behavior and those without it. To examine this hypothesis, we studied an ethnically homogeneous Japanese population, comparing 5-HTTLPR genotype and allele frequencies in those who scored high and low on the Eating Attitudes Test (EAT-26). 6, 7 The Ethics Committee of the National Alcoholism Center, Kurihama National Hospital, approved this study, and all subjects-179 female students (mean age 20.5 ± 2.7 years) at three nursing colleges-gave informed consent. To examine these subjects' eating problems, we used the Japanese standardized version of the EAT-26, 6 ,7 a screening instrument widely used to measure symptoms and characteristics of eating disorders. We also collected information on the subjects' height and weight (current, maximum, and minimum). From their whole blood samples, we extracted genomic DNA and analyzed 5-HTTLPR by PCR amplification, as previously described. 5 We analyzed categorical data using the chi-square test and continuous data using ANOVA. We calculated statistical power with the Power and Precision program. 8 Among 179 subjects completing the questionnaire, 26 (14.5%) designated as 'high scorers' scored at least 20 points, above which we considered them to have abnormal eating behavior. 9 Among the 153 subjects with scores under 20 (ie 'low scorers'), the 5-HTTLPR genotype and allele frequencies were comparable to those of Japanese control subjects in our earlier study, 10 although the S allele frequency in our samples appears higher than that reported for Caucasian control subjects (36.3%). 1 Although genotype frequencies among both high scorers and low scorers were in Hardy-Weinberg equilibrium, the L/L genotype and L allele frequencies were significantly higher among high scorers than Molecular Psychiatry among low scorers ( Table 1 ). The odds ratio (OR) for the L allele was 2.47 (95% CI, 1.34-4.56) for high scorers. Setting the true difference in 5-HTTLPR allele frequencies at 0.24 (0.60-0.36) to correspond with that previously reported for eating disorders, 1 we found that the statistical power of our study to detect the difference between high and low scorers was 89% (␣ = 0.05). Comparison of current, maximum, or minimum body mass index (BMI) across 5-HTTLPR genotypes revealed no apparent relationships between BMI and 5-HTTLPR genotype (Table 1) .
A
This study of a non-clinical sample showed significantly higher L allele frequencies in subjects who might have abnormal eating behaviors. One previous study examining obese people found no relationship between weight control and 5-HTTLPR, 4 and another found a lower S allele frequency in overweight subjects than in normal-weight subjects; 2 however, both studies focused on weight control rather than eating behaviors. As far as we know, this is the first examination of the relationship between abnormal eating behaviors and 5-HTTLPR in non-clinical subjects.
Unlike previously reported eating disorder studies, 1, 2 we observed a higher frequency of the L allele, but not the S allele, among EAT-26 high scorers. The higher frequency of the S allele in Japanese than in Caucasians might have something to do with our findings. Moreover, abnormal eating behaviors in non-clinical subjects might differ from those in clinical subjects with eating disorders. This possibility is partly supported by the finding that high scorers' current, maximum, and minimum BMIs did not differ from those of low scorers (data not shown), hence high scorers could not be directly diagnosed as having eating disorders on the basis of EAT-26 results. In any case, biological heterogeneity, diagnostic uncertainty, and the common prob-lem of population stratification in association studies could play a role in our findings. Replication of this study in larger, independent samples is clearly critical. SIR -Aberrations in the functioning of the serotonergic system have been implicated in many psychiatric illnesses such as depression, aggressive behavior, eating disorders, affective disorders and psychosis. 1 The 102T/C polymorphism of the 5-HT2A receptor is encoded by two alleles, allele 1(TCT) and allele 2 in which C replaces T in the 102nd position (TCC). Allele 2 has a site for the restriction enzyme MspI. 2 Based on these alleles individuals can be genotyped as 1-1 (homozygous for allele 1), 1-2 (heterozygote) and 2-2 (homozygous for allele 2). This polymorphism has been reported to be associated with schizophrenia in a number of studies in various ethnic groups around the world. [3] [4] This is the first time that this polymorphism is being studied in a south Indian population with regard to schizophrenia.
Association between the
A large collaborative study of a European Caucasian population reported an attributable risk of 35% of developing the disease in individuals possessing allele 2. 5 However there are also studies refuting this association which may be due to ethnic differences in the genetic susceptibility to schizophrenia. [6] [7] [8] [9] Some studies have shown an association between this polymorphism and response to antipsychotic medication. [10] [11] [12] The patients participating in the study were recruited from the out-patient and in-patient units of Indira Health Home, a psychiatric hospital based in Hyderabad Andhra Pradesh, after obtaining written consent from the patient and the key relative of the patient.
The sample consisted of 100 patients (61 males and 39 females) with a DSM-IV diagnosis of schizophrenia and 100 normal age-and sex-matched controls between the ages of 18 and 65 yrs. All patients and controls comprised a mixed south Indian population from the states of Andhra Pradesh, Karnataka and Tamil Nadu. Caste was not a criterion in sample selection.
High molecular weight DNA was extracted from venous blood using spin columns (Qiagen, Crawley, UK) and subjected to 35 cycles of PCR amplification at an annealing temperature of 60°C with the reaction mixture containing 2.5 mM of magnesium chloride and the primers 5-TCTGCTACAAGTTCTGGCTT-3′ and 5′-CTGCAGCTTTTTCTCTAGGG-3′. The PCR product was digested with the restriction enzyme MspI overnight. The two alleles T102 (372-bp uncut fragment) and C102 (156 and 216-bp digested fragments) were identified by running the digested products in a 2% agarose gel.
The distribution of genotypes in the control and patient samples is shown in Table 1 . There is a highly significant excess of 2-2 genotype in the patient sample when compared to the controls. The percentage of 1-1 genotype is higher in the control sample than the patient sample (Chi-square = 32.17(2); P = 0.0001).
These results suggest that the 5-HT2A receptor gene or a gene closely linked to it may be involved in the pathogenesis of schizophrenia. Conflicting results by other groups may be indicative of the racial differences in the samples studied. The multi-ethnic and multiracial composition of the Indian population provides a unique opportunity to study the genetic epidemiology and susceptibility of various ethnic and racial groups to a particular disease. Whether or not the 5-HT2A receptor plays a significant role in conferring a suscep- 
